Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOSHUA ZEIDNER

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1174797344
CMS profile
98497
Location
CHAPEL HILL, NC

General Payments · PY2018–2024

$131,016.31

  • Reported across 123 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$31,170.94

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $27,347.50 14
Travel and Lodging $2,887.80 8
Food and Beverage $935.64 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Sumitomo Pharma America, Inc. $10,353.73 6
Daiichi Sankyo Inc. $9,538.55 12
SERVIER PHARMACEUTICALS LLC $7,363.84 9
ABBVIE INC. $2,002.37 3
Genmab U.S., Inc. $1,570.00 2
Astellas Pharma US Inc $222.45 2
AstraZeneca UK Limited $120.00 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $7,646.59 8
PY2019 $12,129.06 23
PY2020 $8,318.94 7
PY2021 $8,664.60 5
PY2022 $25,452.84 21
PY2023 $37,633.34 23
PY2024 $31,170.94 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $52.37 01/23/2024 Travel and Lodging Undisputed 01/23/2026 1106392670 CMS
ABBVIE INC. $1,300.00 01/23/2024 Consulting Fee Undisputed 01/23/2026 1106392672 CMS
ABBVIE INC. $650.00 01/24/2024 Consulting Fee Undisputed 01/23/2026 1106392674 CMS
Astellas Pharma US Inc $75.66 06/15/2024 Food and Beverage Undisputed 01/23/2026 1139371991 CMS
Astellas Pharma US Inc $146.79 09/14/2024 Food and Beverage Undisputed 01/23/2026 1139392164 CMS
AstraZeneca UK Limited $60.00 12/07/2024 Food and Beverage Undisputed 01/23/2026 1093906210 CMS
AstraZeneca UK Limited $60.00 12/09/2024 Food and Beverage Undisputed 01/23/2026 1094008058 CMS
Daiichi Sankyo Inc. $336.75 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1089501548 CMS
Daiichi Sankyo Inc. $253.47 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1089501550 CMS
Daiichi Sankyo Inc. $901.30 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1089501556 CMS
Daiichi Sankyo Inc. $103.92 04/18/2024 Food and Beverage Undisputed 01/23/2026 1089501558 CMS
Daiichi Sankyo Inc. $131.93 04/19/2024 Food and Beverage Undisputed 01/23/2026 1089501546 CMS
Daiichi Sankyo Inc. $60.89 04/19/2024 Food and Beverage Undisputed 01/23/2026 1089501552 CMS
Daiichi Sankyo Inc. $39.92 04/19/2024 Food and Beverage Undisputed 01/23/2026 1089501554 CMS
Daiichi Sankyo Inc. $182.61 04/20/2024 Travel and Lodging Undisputed 01/23/2026 1089501560 CMS
Daiichi Sankyo Inc. $3,547.50 05/15/2024 Consulting Fee Undisputed 01/23/2026 1089501538 CMS
Daiichi Sankyo Inc. $645.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 1089501540 CMS
Daiichi Sankyo Inc. $110.26 06/01/2024 Food and Beverage Undisputed 01/23/2026 1089501544 CMS
Daiichi Sankyo Inc. $3,225.00 06/12/2024 Consulting Fee Undisputed 01/23/2026 1089501542 CMS
Genmab U.S., Inc. $785.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1151759359 CMS
Genmab U.S., Inc. $785.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1151759357 CMS
SERVIER PHARMACEUTICALS LLC $348.19 04/11/2024 Travel and Lodging Undisputed 01/23/2026 1147264738 CMS
SERVIER PHARMACEUTICALS LLC $154.26 04/12/2024 Travel and Lodging Undisputed 01/23/2026 1147264736 CMS
SERVIER PHARMACEUTICALS LLC $15.51 04/12/2024 Food and Beverage Undisputed 01/23/2026 1147264740 CMS
SERVIER PHARMACEUTICALS LLC $658.85 04/12/2024 Travel and Lodging Undisputed 01/23/2026 1147264742 CMS
SERVIER PHARMACEUTICALS LLC $3,400.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 1147264744 CMS
SERVIER PHARMACEUTICALS LLC $17.21 04/12/2024 Food and Beverage Undisputed 01/23/2026 1147264746 CMS
SERVIER PHARMACEUTICALS LLC $7.80 04/12/2024 Food and Beverage Undisputed 01/23/2026 1147264748 CMS
SERVIER PHARMACEUTICALS LLC $42.02 04/12/2024 Food and Beverage Undisputed 01/23/2026 1147264750 CMS
SERVIER PHARMACEUTICALS LLC $2,720.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 1147264752 CMS
Sumitomo Pharma America, Inc. $7,350.00 04/11/2024 Consulting Fee Undisputed 01/23/2026 1148939326 CMS
Sumitomo Pharma America, Inc. $735.00 07/25/2024 Consulting Fee Undisputed 01/23/2026 1148939328 CMS
Sumitomo Pharma America, Inc. $735.00 07/25/2024 Consulting Fee Undisputed 01/23/2026 1148939330 CMS
Sumitomo Pharma America, Inc. $735.00 10/03/2024 Consulting Fee Undisputed 01/23/2026 1148939332 CMS
Sumitomo Pharma America, Inc. $735.00 11/26/2024 Consulting Fee Undisputed 01/23/2026 1148939334 CMS
Sumitomo Pharma America, Inc. $63.73 12/05/2024 Food and Beverage Undisputed 01/23/2026 1148939336 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.